GS
IPXL

GAM Systematic’s Impax Laboratories, Inc. IPXL Stock Holding History

GAM Systematic’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$794K Buy
+39,114
New +$748K 0.11% 331
2017
Q2 		– Sell
-10,912
Closed -$138K – 668
2017
Q1 		$138K Buy
+10,912
New +$132K 0.03% 515
2015
Q4 		– Sell
-5,760
Closed -$203K – 717
2015
Q3 		$203K Buy
+5,760
New +$260K 0.05% 501

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

GAM Systematic's IPXL Position: Q3 2017 in Review

GAM Systematic opened a new position in Impax Laboratories, Inc. (IPXL) in Q3 2017: 39,114 shares worth $794K. The stake represents 0.11% of the portfolio and ranks #331 among its holdings. This is a return to the name: GAM Systematic previously reported a position in IPXL as recently as Q1 2017.

GAM Systematic first reported a position in IPXL in Q3 2015 and has held it in 3 quarters since. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.

  • GAM Systematic held 39,114 shares of Impax Laboratories, Inc. worth $794K as of Q3 2017.
  • Impax Laboratories, Inc. was a new GAM Systematic position in Q3 2017.
  • Impax Laboratories, Inc. made up 0.11% of GAM Systematic's portfolio in Q3 2017, its #331 holding.
  • GAM Systematic first reported a position in Impax Laboratories, Inc. in Q3 2015 and has held it in 3 quarters since.
  • 189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.